Bioventus Inc. Class A Common Stock

Bioventus Inc. Class A Common Stock represents ownership in Bioventus Inc., a medical technology company headquartered in Durham, North Carolina. Bioventus focuses on developing and commercializing orthobiologic and musculoskeletal treatments that engage and enhance the body’s natural healing processes. Its portfolio is organized into three core business areas: Pain Treatments, Restorative Therapies, and Surgical Solutions. In pain management, the company offers office-based therapies such as hyaluronic acid injections for knee osteoarthritis and peripheral nerve stimulation devices for targeted pain relief. Restorative Therapies include products like the EXOGEN Ultrasound Bone Healing System and other bone-healing stimulation technologies designed to support fracture recovery. Surgical Solutions encompasses a broad range of orthobiologic implants, bone graft substitutes, and ultrasonic surgical systems used in orthopedic, spine, neurosurgery, trauma, and sports medicine procedures. Bioventus primarily serves specialist physicians and hospital-based clinical teams in the United States, complemented by selected international markets, positioning the company as a focused provider of musculoskeletal care products across multiple stages of treatment.

Sector

Healthcare

Industry

Medical Devices

CEO

Mr. Robert E. Claypoole

Employees

940

Headquarters

Durham, NC, United States

Website

www.bioventus.com